We decided to focus exclusively on CD4+ Tregs, because too little had been published on the role of CD8+ Tregs in cancer for a reliable analysis: we found only three articles on CD8+ Tregs [31,32,33] and one on CD4+CD8+ Tregs [34] among the 341 articles we analyzed (Figure 1). The gene discussed is CD4; the disease is cancer.